Olivier Gaide

7.5k total citations · 3 hit papers
79 papers, 5.7k citations indexed

About

Olivier Gaide is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Olivier Gaide has authored 79 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 26 papers in Oncology and 24 papers in Dermatology. Recurrent topics in Olivier Gaide's work include Nonmelanoma Skin Cancer Studies (18 papers), NF-κB Signaling Pathways (12 papers) and Cutaneous Melanoma Detection and Management (11 papers). Olivier Gaide is often cited by papers focused on Nonmelanoma Skin Cancer Studies (18 papers), NF-κB Signaling Pathways (12 papers) and Cutaneous Melanoma Detection and Management (11 papers). Olivier Gaide collaborates with scholars based in Switzerland, United States and France. Olivier Gaide's co-authors include Jürg Tschopp, Pascal Schneider, Olivier Micheau, Fabio Martinon, Susanne M.A. Lens, Jürg Tschopp, Aubry Tardivel, Lars E. French, Margot Thome and Sylvie Hertig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Olivier Gaide

70 papers receiving 5.5k citations

Hit Papers

NF-κB Signals Induce the Expression of c-FLIP 2001 2026 2009 2017 2001 2019 2015 200 400 600

Peers

Olivier Gaide
Nam H. Dang United States
Ossama Tawfik United States
Philip J. Coates United Kingdom
Zsuzsanna Varga Switzerland
Kenneth E. Lipson United States
Rex C. Bentley United States
Nam H. Dang United States
Olivier Gaide
Citations per year, relative to Olivier Gaide Olivier Gaide (= 1×) peers Nam H. Dang

Countries citing papers authored by Olivier Gaide

Since Specialization
Citations

This map shows the geographic impact of Olivier Gaide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Gaide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Gaide more than expected).

Fields of papers citing papers by Olivier Gaide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Gaide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Gaide. The network helps show where Olivier Gaide may publish in the future.

Co-authorship network of co-authors of Olivier Gaide

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Gaide. A scholar is included among the top collaborators of Olivier Gaide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Gaide. Olivier Gaide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinj, Rémy, Sushil Allen Luis, Martine Raphaël, Jean Bourhis, & Olivier Gaide. (2025). Phase 1 dose escalation trial of FLASH radiotherapy in patients with skin metastases from melanoma. 3. 100507–100507. 1 indexed citations
2.
Wunderlich, Klaus, Carmen Orte Cano, Mariano Suppa, et al.. (2025). High-Frequency Basal Cell Carcinoma: Demographic, Clinical, and Histopathological Features in a Belgian Cohort. Journal of Clinical Medicine. 14(13). 4678–4678.
3.
Kinj, Rémy, Olivier Gaide, Wendy Jeanneret‐Sozzi, et al.. (2024). Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol. Clinical and Translational Radiation Oncology. 45. 100743–100743. 19 indexed citations
4.
Corre, Tanguy, et al.. (2024). Positive Impact of UV Photography on Individual Sun Protection: A Swiss Feasibility Study. International Journal of Public Health. 69. 1607604–1607604.
5.
Pastor, Damien, et al.. (2023). Mpox (variole du singe) : l’œil du dermatologue. Revue Médicale Suisse. 19(820). 614–617. 1 indexed citations
6.
Bisig, Bettina, Anne Cairoli, Olivier Gaide, et al.. (2022). Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(4). 653–657. 2 indexed citations
7.
Gaide, Olivier, Fernanda Herrera, Wendy Jeanneret Sozzi, et al.. (2022). Comparison of ultra-high versus conventional dose rate radiotherapy in a patient with cutaneous lymphoma. Radiotherapy and Oncology. 174. 87–91. 59 indexed citations
8.
Bourhis, Jean, Wendy Jeanneret Sozzi, Patrik Gonçalves Jorge, et al.. (2019). Treatment of a first patient with FLASH-radiotherapy. Radiotherapy and Oncology. 139. 18–22. 597 indexed citations breakdown →
9.
Gaide, Olivier, et al.. (2016). Ingenol Mebutate 500 μg for Treatment of the Scalp in Refractory Field Cancerization. Dermatology. 232(Suppl. 1). 7–8. 2 indexed citations
10.
Gaide, Olivier, Ryan Emerson, Xiaodong Jiang, et al.. (2015). Common clonal origin of central and resident memory T cells following skin immunization. Nature Medicine. 21(6). 647–653. 217 indexed citations
11.
Kuonen, François & Olivier Gaide. (2014). Nouvelle lumière sur la thérapie photodynamique cutanée. Revue Médicale Suisse. 10(424). 754–759. 1 indexed citations
12.
Hofbauer, Günther F.L., M.D. Anliker, Wolf‐­Henning Boehncke, et al.. (2014). Swiss clinical practice guidelines on field cancerization of the skin. Swiss Medical Weekly. 144(5152). w14026–w14026. 40 indexed citations
13.
Feldmeyer, Laurence & Olivier Gaide. (2013). Carcinome de Merkel : (r)évolution. Revue Médicale Suisse. 9(380). 723–729.
14.
Dunkel, N., Laure Willen, Margret L. Casal, et al.. (2011). Molecular and Therapeutic Characterization of Anti-ectodysplasin A Receptor (EDAR) Agonist Monoclonal Antibodies. Journal of Biological Chemistry. 286(35). 30769–30779. 32 indexed citations
15.
Gaide, Olivier. (2009). Gene therapy and protein therapy of ectodermal dysplasias: A perspective. American Journal of Medical Genetics Part A. 149A(9). 2042–2044.
16.
Mauldin, Elizabeth A., Olivier Gaide, Pascal Schneider, & Margret L. Casal. (2009). Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X‐linked ectodermal dysplasia. American Journal of Medical Genetics Part A. 149A(9). 2045–2049. 36 indexed citations
17.
Watanabe, Hideki, Samuel Gehrke, Emmanuel Contassot, et al.. (2008). Danger Signaling through the Inflammasome Acts as a Master Switch between Tolerance and Sensitization. The Journal of Immunology. 180(9). 5826–5832. 73 indexed citations
18.
Gaide, Olivier & Hal M. Hoffman. (2007). Insight into the inflammasome and caspase-activating mechanisms. Expert Review of Clinical Immunology. 4(1). 61–77. 6 indexed citations
19.
Bossen, Claudia, Aubry Tardivel, Jean-Luc Bodmer, et al.. (2006). Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human. Journal of Biological Chemistry. 281(20). 13964–13971. 346 indexed citations
20.
Gaide, Olivier, Fabio Martinon, Olivier Micheau, et al.. (2001). Carma1, a CARD‐containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF‐κB activation1. FEBS Letters. 496(2-3). 121–127. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026